share_log
Breakings ·  Jun 18 20:31
Day One Biopharmaceuticals Inc: Expects First Patient to Be Dosed in Phase I Study in Q4 of 2024 or Q1 of 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment